{"id":"W2071343804","doi":"10.1056/nejmoa062382","title":"A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":785,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Monoclonal antibody; Monoclonal; Immunology; Interleukin 23; Ixekizumab; Interleukin; Interleukin 2; Dermatology; Antibody; Cytokine; Secukinumab; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007887912,0.0003255916,0.0005732712,0.0002948388,0.0001635191,0.0002268294,0.0002873142,0.0004382126,0.002650472],"category_scores_gemma":[0.0004814721,0.0001091106,0.0003217827,0.0002004358,0.0002470974,0.0001524199,0.0001454778,0.0009549627,0.0004698604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001672333,"about_ca_system_score_gemma":0.0002672221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001861826,"about_ca_topic_score_gemma":0.0003477706,"domain_scores_codex":[0.9998024,0.00009165579,0.00001752446,0.00002237854,0.00004320328,0.00002289826],"domain_scores_gemma":[0.9998145,0.00005889584,0.00005594181,0.000008413159,0.00001739436,0.00004500787],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0971866,0.008444934,0.004431368,0.003169216,0.0009188705,0.0005164102,0.0001033163,0.0009527716,0.09779575,0.0005437776,0.006172641,0.7797644],"study_design_scores_gemma":[0.5208418,0.3360849,0.03237586,0.001092952,0.00205975,0.005846194,0.00009422506,0.001952864,0.03636515,0.0008527072,0.06236263,0.00007090875],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8455439,0.1413754,0.002740099,0.00205111,0.0009072005,0.001454182,0.0002943348,0.0002135427,0.005420309],"genre_scores_gemma":[0.9579127,0.03373829,0.003804888,0.001132091,0.0006703689,0.000811762,0.0003425712,0.00001168452,0.001575595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002650472,"threshold_uncertainty_score":0.008866727,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03264787616484358,"score_gpt":0.3145769993690694,"score_spread":0.2819291232042258,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}